High-Resolution Analysis of the Relationship Between Dose and Molecular Response in CP-CML Patients Treated with Ponatinib or Imatinib
Year: 2014
Type: article
Source: Blood
Institutions: ARIAD Pharmaceuticals (United States), University of Bologna, The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute, Centre Hospitalier Universitaire de Poitiers, Jena University Hospital, The University of Adelaide, University of California, San Francisco, University of Michigan
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2551885871
